179 related articles for article (PubMed ID: 34098886)
1. SOX14 hypermethylation as a tumour biomarker in cervical cancer.
Zhao J; Cao H; Zhang W; Fan Y; Shi S; Wang R
BMC Cancer; 2021 Jun; 21(1):675. PubMed ID: 34098886
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma.
Wang R; van Leeuwen RW; Boers A; Klip HG; de Meyer T; Steenbergen RD; van Criekinge W; van der Zee AG; Schuuring E; Wisman GB
Oncotarget; 2016 Dec; 7(49):80735-80750. PubMed ID: 27738327
[TBL] [Abstract][Full Text] [Related]
3. Identification of DNA methylation of SOX9 in cervical cancer using methylated-CpG island recovery assay.
Wu JH; Liang XA; Wu YM; Li FS; Dai YM
Oncol Rep; 2013 Jan; 29(1):125-32. PubMed ID: 23064448
[TBL] [Abstract][Full Text] [Related]
4. Real-time colorimetric detection of DNA methylation of the
Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
[TBL] [Abstract][Full Text] [Related]
5. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
[TBL] [Abstract][Full Text] [Related]
6. The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer.
Zhang W; Cao H; Yang J; Zhao J; Liang Z; Kang X; Wang R
BMC Cancer; 2022 Jun; 22(1):636. PubMed ID: 35681118
[TBL] [Abstract][Full Text] [Related]
7. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation analysis in liquid-based cytology for cervical cancer screening.
Apostolidou S; Hadwin R; Burnell M; Jones A; Baff D; Pyndiah N; Mould T; Jacobs IJ; Beddows S; Kocjan G; Widschwendter M
Int J Cancer; 2009 Dec; 125(12):2995-3002. PubMed ID: 19609949
[TBL] [Abstract][Full Text] [Related]
9. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
[TBL] [Abstract][Full Text] [Related]
10. Detection of hypermethylated genes as markers for cervical screening in women living with HIV.
Kremer WW; Van Zummeren M; Novianti PW; Richter KL; Verlaat W; Snijders PJ; Heideman DA; Steenbergen RD; Dreyer G; Meijer CJ
J Int AIDS Soc; 2018 Aug; 21(8):e25165. PubMed ID: 30101434
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
12. LINE-1 hypermethylation in white blood cell DNA is associated with high-grade cervical intraepithelial neoplasia.
Barchitta M; Quattrocchi A; Maugeri A; Canto C; La Rosa N; Cantarella MA; Spampinato G; Scalisi A; Agodi A
BMC Cancer; 2017 Aug; 17(1):601. PubMed ID: 28854904
[TBL] [Abstract][Full Text] [Related]
13. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
[TBL] [Abstract][Full Text] [Related]
14. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.
Eijsink JJ; Lendvai Á; Deregowski V; Klip HG; Verpooten G; Dehaspe L; de Bock GH; Hollema H; van Criekinge W; Schuuring E; van der Zee AG; Wisman GB
Int J Cancer; 2012 Apr; 130(8):1861-9. PubMed ID: 21796628
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia.
El-Zein M; Cheishvili D; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Szyf M; Franco EL;
Int J Cancer; 2020 Sep; 147(5):1264-1274. PubMed ID: 31983058
[TBL] [Abstract][Full Text] [Related]
16. [Death-associated protein kinase promoter (DAPK) hypermethylation in uterine cervical cancer and intraepithelial neoplasia in Uyghur nationality women].
Niyazi M; Liu XW; Zhu KC
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):31-4. PubMed ID: 22490852
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel DNA methylation markers in cervical cancer.
Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
[TBL] [Abstract][Full Text] [Related]
18. Aberrant single-minded homolog 1 methylation as a potential biomarker for cervical cancer.
Kim HJ; Kim CY; Jin J; Bae MK; Kim YH; Ju W; Kim YH; Kim SC
Diagn Cytopathol; 2018 Jan; 46(1):15-21. PubMed ID: 29063719
[TBL] [Abstract][Full Text] [Related]
19. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape.
Snellenberg S; De Strooper LM; Hesselink AT; Meijer CJ; Snijders PJ; Heideman DA; Steenbergen RD
BMC Cancer; 2012 Nov; 12():551. PubMed ID: 23176198
[TBL] [Abstract][Full Text] [Related]
20. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.
Xu J; Xu L; Yang B; Wang L; Lin X; Tu H
Int J Clin Exp Pathol; 2015; 8(2):1674-81. PubMed ID: 25973053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
